Dr. David Meya is an Associate Professor of Medicine at Makerere University College of Health Sciences and an Adjunct Associate Professor at the University of Minnesota. He has been involved in clinical research of central nervous system infections and complications, with a focus on HIV Immune Reconstitution Inflammatory syndrome (IRIS). Dr. Meya has led epidemiological and translational research studies as well as randomized clinical trials in prevention and treatment of Cryptococcal Meningitis. Dr. Meya also has a specific interest in public health interventions to prevent meningitis at population level. He has advocated for cryptococcal antigen (CrAg) screening as a strategy to reduce deaths and hospitalizations from cryptococcal meningitis. Dr. Meya chairs the Advanced HIV Disease Technical Working group at the Ministry of Health. He has been the Principal Investigator on NIH R01, CDC U01, and UK MRC grants and continues to be involved in advocacy to improve clinical care and outcomes in a predominantly HIV-infected patient population with limited resources for health focusing on advanced HIV disease.